NMPA Approval

Levodopa and Benserazide Hydrochloride Capsules

Approval Number

国药准字H44023472

Company广州白云山汉方现代药业有限公司

Registration Date

September 25, 2019

Drug Information

Generic Name

多巴丝肼胶囊

Dosage Form

胶囊剂

Strength

左旋多巴200mg与苄丝肼50mg(相当于盐酸苄丝肼57mg)

Drug Type

化学药品

Registration Date

September 25, 2019

Company Information

Applicant Company

Company Name广州白云山汉方现代药业有限公司

Manufacturing Company

Company Name广州白云山汉方现代药业有限公司

Company Address

广州市从化温泉大道8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

多巴丝肼胶囊 - NMPA 批准文号 | MedPath